Real-Time fMRI to Enhance Interventions That Change Delay Discounting
NCT ID: NCT04828577
Last Updated: 2025-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
100 participants
INTERVENTIONAL
2023-01-13
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimisation of Functional MRI-based Neurofeedback for Alcohol Use Disorders
NCT02406456
Neurofeedback & Alcohol Dependence
NCT02486900
A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder
NCT03535129
fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults
NCT01320748
Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder
NCT03829761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real Time Neurofeedback
Real time neurofeedback will be based on a classifier of increasing or decreasing delay discounting fMRI patterns. Participants will try to modulate their discounting rate based on neurofeedback via a visual dial, during an fMRI scan. Participants will be told they will be controlling the visual dial.
Real Time Neurofeedback
Participants receive feedback from own brain activity.
"Idealized"/Sham Neurofeedback
Rather than using the output of a classifier, the visual dial will display perfect "modulation" of increasing and decreasing delay discounting and participants will told that they will not be controlling the visual dial.
"Idealized"/Sham Neurofeedback
Participants receive idealized feedback not related to their own brain activity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real Time Neurofeedback
Participants receive feedback from own brain activity.
"Idealized"/Sham Neurofeedback
Participants receive idealized feedback not related to their own brain activity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be 21 years of age or older
* have a desire to quit or cut down on their drinking, but do not have proximate plans to enroll in treatment for AUD during the study period
Exclusion Criteria
* having a current diagnosis of any psychotic disorder
* having a history of seizure disorders or traumatic brain injury
* having any contraindication for participation in the MRI sessions
* reporting current pregnancy or lactation
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fralin Biomedical Research Institute
UNKNOWN
Virginia Polytechnic Institute and State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen M LaConte, PhD
Role: PRINCIPAL_INVESTIGATOR
Fralin Biomedical Research Institute (FBRI) at VTC
Warren K Bickel, PhD
Role: PRINCIPAL_INVESTIGATOR
Fralin Biomedical Research Institute (FBRI) at VTC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RP2B/21-305
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.